BLOG POST

13 Pharma Companies Withdraw Malaria Monotherapies

By
May 12, 2006

The WHO announced yesterday that 13 producers of single-drug artemisinin medicines for malaria have agreed to voluntarily phase them out in order to slow the progressions of drug resistance.

Topics

DISCLAIMER & PERMISSIONS

CGD's publications reflect the views of the authors, drawing on prior research and experience in their areas of expertise. CGD is a nonpartisan, independent organization and does not take institutional positions. You may use and disseminate CGD's publications under these conditions.